1. Allegranzi, B, Bagheri Nejad, S, Combescure, C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011;377:228–241.
2. Bagheri Nejad, S, Allegranzi, B, Syed, SB, Ellis, B, Pittet, D. Health-care–associated infection in Africa: a systematic review. Bull World Health Org 2011;89:757–765.
3. Ling, ML, Apisarnthanarak, A, Madriaga, G. The burden of healthcare-associated infections in Southeast Asia: a systematic literature review and meta-analysis. Clin Infect Dis 2015;60:1690–1699.
4. Bates, DW, Larizgoitia, I, Prasopa-Plaizier, N, Jha, AK. Global priorities for patient safety research. BMJ 2009;338:b1775.
5. Burke, JP. Infection control—a problem for patient safety. N Engl J Med 2003;348:651–656.
6. Sun, B. Nosocomial infection in China: management status and solutions. Am J Infect Control 2016;44:851–852.
8. Xu, H, Sun, J, Gu, A, et al. Prevention and control of catheter-associated urinary tract infection in China. Chin J Infect Control 2016;15:671–675.
9. Wang, Y, Zhang, X, Li, S, Guo, Y, Liu, Q, Wang, Y. Comparative analysis of hospital beds resource utilization and average days of stay between China and abroad. Chin J Hosp Admin 2016;32:361–364.
10. Weiss, AJ, Elixhauser, A. Overview of hospital stays in the United States, 2012: Statistical Brief #180. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: US Agency for Healthcare Research and Quality; 2006.
11. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013.
12. Jia, H, Hou, T, Li, W, et al. Economic loss due to healthcare-associated infection in 68 general hospitals in China. Chin J Infect Control 2016;15:637–641.
15. Anand, S, Fan, VY, Zhang, J, et al. China’s human resources for health: quantity, quality, and distribution. Lancet 2008;372:1774–1781.
16. Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198–1208.
17. Wang, J, Hu, J, Harbarth, S, Pittet, D, Zhou, M, Zingg, W. Burden of healthcare-associated infections in China: results of the 2015 point prevalence survey in Dong Guan City. J Hosp Infect 2017;96:132–138.
18. Zhang, Y, Zhang, J, Wei, D, Yang, Z, Wang, Y, Yao, Z. Annual surveys for point-prevalence of healthcare-associated infection in a tertiary hospital in Beijing, China, 2012–2014. BMC Infect Dis 2016;16:161.
19. Li, C, Wen, X, Ren, N, et al. Point-prevalence of healthcare-associated infection in China in 2010: a large multicenter epidemiological survey. Infect Control Hosp Epidemiol 2014;35:1436–1437.
20. Xie, DS, Xiong, W, Xiang, LL, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007–2008. J Hosp Infect 2010;76:150–155.
21. Liu, JY, Wu, YH, Cai, M, Zhou, CL. Point-prevalence survey of healthcare-associated infections in Beijing, China: a survey and analysis in 2014. J Hosp Infect 2016;93:271–279.
22. Tao, XB, Qian, LH, Li, Y, et al. Hospital-acquired infection rate in a tertiary care teaching hospital in China: a cross-sectional survey involving 2434 inpatients. Int J Infect Dis 2014;27:7–9.
23. Chen, Y, Zhao, JY, Shan, X, et al. A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals. J Hosp Infect 2017;95:105–111.
24. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, The, PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
25. von Elm, E, Altman, DG, Egger, M, Pocock, SJ, Gøtzsche, PC, Vandenbroucke, JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–1457.
27. Li, Y, Huai, Y, Varma, J, Rao, C. Healthcare-associated infection in mainland China: a systematic review of point prevalence survey literature. ID Week: San Diego, CA; 2012.
28. Ren, N, Wen, X, Wu, A. Nationwide cross-sectional survey on healthcare-associated infection in 2014. Chin J Infect Control 2016;15:83–87.
29. Cai, Y, Venkatachalam, I, Tee, NW, et al. Prevalence of healthcare-associated infections and antimicrobial use among adult inpatients in Singapore acute-care hospitals: results from the first national point prevalence survey. Clin Infect Dis 2017;64:S61–S67.
30. Morioka, H, Hirabayashi, A, Iguchi, M, et al. The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: a pilot study. Am J Infect Control 2016;44:e119–e123.
31. Li, Y, Xu, J, Wang, F, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood) 2012;31:1075–1082.
32. Wang, Z, Zhang, H, Han, J, Xing, H, Wu, MC, Yang, T. Deadly sins of antibiotic abuse in China. Infect Control Hosp Epidemiol 2017;38:758–759.
33. Zingg, W, Hopkins, S, Gayet-Ageron, A, Holmes, A, Sharland, M, Suetens, C. Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey. Lancet Infect Dis 2017;17:381–389.
34. Zhou, Y, Zhang, D, Chen, Y, et al. Healthcare-associated infections and Shanghai clinicians: a multicenter cross-sectional study. PLoS One 2014;9:e105838.
35. Yin, A, Ma, L, Deng, L, Chen, X, Tang, A. Cross-sectional surveys on healthcare-associated infection in a children’s hospital. Chin J Infect Control 2015;14:769–771.
36. Sohn, AH, Garrett, DO, Sinkowitz-Cochran, RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001;139:821–827.
37. Li, G, Zhu, D, Wang, F, et al. The distribution and antibiotic resistance of clinical isolates from blood culture in 2012 CHINET surveillance program in China. Chin J Infect Chemother 2014;14:474–481.